Topic

Insurance Approval

A collection of 819 issues

How Long Does It Take to Get Hemgenix (etranacogene dezaparvovec) Approved by Humana in New Jersey? Complete Timeline Guide

Answer Box: What You Need to Know Getting Hemgenix (etranacogene dezaparvovec) approved by Humana in New Jersey typically takes 7-30 days for standard review, or 72 hours for expedited cases. The fastest path requires complete documentation upfront: Factor IX levels ≤2%, bleeding history, genetic confirmation, and liver function tests. Start

How to Get Fintepla (fenfluramine) Covered by Humana in New York: Complete Guide with Forms and Appeals

Answer Box: Getting Fintepla Covered by Humana in New York Fintepla (fenfluramine) requires prior authorization from Humana for Dravet syndrome and Lennox-Gastaut syndrome patients. The fastest path to approval involves three critical steps: 1) Complete REMS enrollment for both prescriber and patient, 2) Submit baseline echocardiogram showing cardiac safety, and

The Requirements Checklist to Get Retevmo (selpercatinib) Covered by UnitedHealthcare in Pennsylvania

Answer Box: Fast Track to Approval To get Retevmo (selpercatinib) covered by UnitedHealthcare in Pennsylvania: 1) Confirm RET fusion-positive status with FDA-approved testing (FoundationOne CDx preferred), 2) Submit prior authorization through UnitedHealthcare provider portal with complete molecular pathology reports and clinical documentation, 3) If denied, file internal appeal within 6

How to Get Carbaglu (Carglumic Acid) Covered by Cigna in Illinois: Appeals Guide with Forms and Timelines

Answer Box: Getting Carbaglu Covered by Cigna in Illinois Fastest path to approval: Submit prior authorization with genetic/biochemical confirmation of NAGS deficiency, elevated plasma ammonia levels, and specialist consultation. If denied, file internal appeal within 180 days, then external review within 30 days of final denial through Illinois Department

Getting Naglazyme (Galsulfase) Covered by Aetna in Pennsylvania: Coding, Appeals, and Authorization Guide

Quick Answer: Getting Naglazyme Covered by Aetna in Pennsylvania Naglazyme (galsulfase) for MPS VI requires prior authorization from Aetna with specific documentation: confirmed diagnosis via enzyme assay or genetic testing, baseline functional assessments (like six-minute walk tests), and specialist involvement. Bill using HCPCS J1458 under the medical benefit at 1

How to Get Ilaris (Canakinumab) Covered by Blue Cross Blue Shield in Washington: Complete Guide to Prior Authorization and Appeals

Answer Box: Fast Track to Approval Getting Ilaris (canakinumab) covered by Blue Cross Blue Shield in Washington requires prior authorization with specific documentation. Here's the fastest path: 1. Gather diagnostic evidence: Yamaguchi criteria for AOSD or ILAR criteria for SJIA, plus elevated inflammatory markers (ESR, CRP, ferritin >

Renewing Voxzogo (Vosoritide) Approval with UnitedHealthcare in Washington: 2025 Requirements & Timeline

Quick Answer: Voxzogo Renewal Requirements UnitedHealthcare requires annual reauthorization for Voxzogo (vosoritide) with documented clinical response and open epiphyses. Start renewal 60 days before expiration. Key documents: updated growth data showing improved velocity, bone age confirmation of open growth plates, and provider attestation of continued benefit. Submit through OptumRx provider

How to Get Zolgensma Approved by UnitedHealthcare in New York: Complete Prior Authorization Guide

Answer Box: Getting Zolgensma Covered by UnitedHealthcare in New York Zolgensma requires prior authorization from UnitedHealthcare for SMA patients under 2 years old with confirmed SMN1 gene mutations. The fastest path: (1) Submit genetic testing results and clinical documentation through the UHC Provider Portal, (2) Request expedited review if medically

How to Get Arikayce Covered by Humana in Washington: Prior Authorization Guide and Appeals Process

Quick Answer: Getting Arikayce Covered by Humana in Washington Arikayce (amikacin liposome inhalation) requires prior authorization from Humana and is typically approved only for refractory MAC lung disease after 6+ months of failed standard therapy. In Washington, if denied, you have 60 days to request external review through an Independent

How to Get Elelyso (Taliglucerase Alfa) Covered by Aetna CVS Health in Illinois: Complete Guide with Forms, Timelines, and Appeal Scripts

Answer Box: Quick Path to Elelyso Coverage Elelyso (taliglucerase alfa) requires prior authorization from Aetna CVS Health in Illinois. Submit your PA request at least two weeks in advance via the Availity provider portal with complete Gaucher disease Type 1 documentation. Good news: Illinois banned step therapy for specialty medications